| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 3 securities · may seek to influence control | ||||||
|
Biodesix Inc
13D/A
BDSX · 09075X207
|
22.3% |
11/12/2026
Event 11/10/2026
|
||||
| Schuler Jack W | 22.3% | |||||
| Jack W. Schuler Living Trust | 5.9% | |||||
| Jack W. Schuler 2026 GRAT | 16.2% | |||||
|
Aspira Women's Health Inc.
13D/A
AWHL · 04537Y208
|
8.7% |
6/11/2026
Event 6/5/2026
|
||||
| Schuler Jack W | 8.7% | |||||
| Jack W. Schuler Living Trust | 8.6% | |||||
|
Biodesix, Inc.
13D/A
BDSX · 09075X108
|
26.0% |
9/3/2025
Event 8/29/2025
|
||||
| Schuler Jack W | 26.0% | |||||
| Jack W. Schuler Living Trust | 16.0% | |||||
| Jack W. Schuler 2025 GRAT | 9.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.